EP0550595A4 - Methods - Google Patents
MethodsInfo
- Publication number
- EP0550595A4 EP0550595A4 EP19910917436 EP91917436A EP0550595A4 EP 0550595 A4 EP0550595 A4 EP 0550595A4 EP 19910917436 EP19910917436 EP 19910917436 EP 91917436 A EP91917436 A EP 91917436A EP 0550595 A4 EP0550595 A4 EP 0550595A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58732290A | 1990-09-24 | 1990-09-24 | |
US587322 | 1990-09-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0550595A1 EP0550595A1 (en) | 1993-07-14 |
EP0550595A4 true EP0550595A4 (en) | 1993-09-08 |
Family
ID=24349331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910917436 Ceased EP0550595A4 (en) | 1990-09-24 | 1991-09-18 | Methods |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0550595A4 (en) |
JP (1) | JPH06501468A (en) |
AU (1) | AU652583B2 (en) |
CA (1) | CA2092177A1 (en) |
WO (1) | WO1992004899A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9201803D0 (en) * | 1992-01-28 | 1992-03-11 | Smithkline Beecham Corp | Methods |
GB9217116D0 (en) * | 1992-08-13 | 1992-09-23 | Smithkline Beecham Corp | Methods |
SK156698A3 (en) * | 1996-05-17 | 1999-06-11 | Anormed Inc | Use of substituted azaspirane in the treatment of asthma |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
-
1991
- 1991-09-18 JP JP3516064A patent/JPH06501468A/en active Pending
- 1991-09-18 AU AU86310/91A patent/AU652583B2/en not_active Ceased
- 1991-09-18 WO PCT/US1991/006778 patent/WO1992004899A1/en not_active Application Discontinuation
- 1991-09-18 EP EP19910917436 patent/EP0550595A4/en not_active Ceased
- 1991-09-18 CA CA002092177A patent/CA2092177A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY vol. 11, no. 7, 1989, pages 839 - 846 BADGER, A.M. ET AL 'INHIBITION OF ANIMAL MODELS OF AUTOIMMUNE DISEASE AND THE INDUCTION OF NON-SPECIFIC SUPPRESSOR CELLS BY SK&F 105685 AND RELATED AZASPIRANES' * |
JOURNAL OF AUTOIMMUNITY vol. 6, no. 1, February 1993, pages 39 - 49 RABINOVITCH, A. ET AL 'PREVENTION OF DIABETES AND INDUCTION OF NON-SPECIFIC SUPPRESSOR CELL ACTIVITY IN THE BB RAT BY AN IMMUNOMODULATORY AZASPIRANE, SK&F 106610' * |
JOURNAL OF MEDICINAL CHEMISTRY vol. 33, no. 11, November 1990, pages 2963 - 2970 BADGER, A.M. ET AL 'ANTIARTHRITIC AND SUPPRESSOR CELL INDUCING ACTIVITY OF AZASPIRANES: STRUCTURE-FUNCTION RELATIONSHIPS OF A NOVEL CLASS OF IMMUNOMODULATORY AGENTS' * |
See also references of WO9204899A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1992004899A1 (en) | 1992-04-02 |
CA2092177A1 (en) | 1992-03-25 |
AU652583B2 (en) | 1994-09-01 |
EP0550595A1 (en) | 1993-07-14 |
JPH06501468A (en) | 1994-02-17 |
AU8631091A (en) | 1992-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4190756D2 (en) | Mikrotom | |
DE69125252D1 (en) | Röntgentherapie-simulatormachine | |
EP0440282A3 (en) | Sensormatrix | |
DE69126781D1 (en) | Fabry-perot-modulator | |
EP0463302A3 (en) | Pinchcock | |
DE69116171D1 (en) | Photo- und biologisch-abbaubare polyethen-copolymere | |
DE69127252D1 (en) | Linearlager | |
EP0465262A3 (en) | Polysilethylenesiloxane | |
DE4092449D2 (en) | Taschenfederkernmatratze | |
EP0465263A3 (en) | Polysilethylenesiloxane | |
EP0442596A3 (en) | Echelle-polychromator | |
DE4191708D2 (en) | Festkoerperlaser | |
AU111085S (en) | Sunlounger | |
EP0467207A3 (en) | Purinderivate | |
EP0458340A3 (en) | Slitterscorer | |
CS262591A3 (en) | Indolonaphthyridines | |
EP0444458A3 (en) | Pulsdopplerradar | |
EP0441276A3 (en) | Electrophotoreceptor | |
DE4092685D2 (en) | Mehrkomponenten-kleb- und -werkstoffverarbeitungssystem | |
EP0464900A3 (en) | 2-biphenyl-carbapenems | |
EP0447954A3 (en) | Spray-station | |
EP0550595A4 (en) | Methods | |
EP0439820A3 (en) | Vacuumswitch | |
EP0442371A3 (en) | Bisglycosides | |
EP0455870A3 (en) | Laboratory-centrifuge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19930325 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930720 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19950911 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ANORMED INC |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
RTI1 | Title (correction) |
Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS |
|
RTI1 | Title (correction) |
Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS |
|
RTI1 | Title (correction) |
Free format text: USE OF AZASPIRANES FOR THE MANUFACTURE OF A MEDIAMENT FOR THE TREATMENT OF DISEASES CAUSED BY EXCESSIVE GLUCOSE LEVELS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20000101 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1012271 Country of ref document: HK |